A radiolabeled nucleoside analogue, a method for preparing the same and the use thereof

The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provide...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WANG, HSIN-ELL, WENG, MAOI, LIN, WUU-JYH, WANG, MEI-HUI, CHANG, YU, CHEN, CHUAN-LIN, LIN, CHIH-YUAN, YU, HUNG-MAN, KUO, WEI-TI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention related to a radiolabeled nucleoside analogue, wherein comprises a radioiodinated [123/131I] and a nucleoside analogue being selected from the group consisting of Cytosine, Thymine, Uracil, and analogues thereof. A method for the radiolabeled nucleoside analogue is also provided in the present invention and thereby, the nucleoside analogue with longer in vivo half-life time and higher stability in the serum may be produced. A pharmaceutical composition of radiolabeled nucleoside analogue is further provided for a promising proliferation probe for tumor diagnosis.